1. Home
  2. BANC vs EVO Comparison

BANC vs EVO Comparison

Compare BANC & EVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Banc of California Inc.

BANC

Banc of California Inc.

HOLD

Current Price

$19.64

Market Cap

2.9B

Sector

Finance

ML Signal

HOLD

Logo Evotec SE

EVO

Evotec SE

HOLD

Current Price

$2.98

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BANC
EVO
Founded
1941
1993
Country
United States
Germany
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.9B
1.1B
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
BANC
EVO
Price
$19.64
$2.98
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
9
1
Target Price
$19.61
$7.00
AVG Volume (30 Days)
2.0M
137.3K
Earning Date
01-22-2026
11-05-2025
Dividend Yield
2.02%
N/A
EPS Growth
N/A
N/A
EPS
1.03
N/A
Revenue
$1,019,965,000.00
$887,396,457.00
Revenue This Year
$4.33
N/A
Revenue Next Year
$14.27
$8.80
P/E Ratio
$19.23
N/A
Revenue Growth
147.22
N/A
52 Week Low
$11.52
$2.84
52 Week High
$20.17
$5.10

Technical Indicators

Market Signals
Indicator
BANC
EVO
Relative Strength Index (RSI) 67.55 40.81
Support Level $19.51 $2.91
Resistance Level $20.07 $3.05
Average True Range (ATR) 0.40 0.09
MACD -0.00 0.01
Stochastic Oscillator 66.78 28.00

Price Performance

Historical Comparison
BANC
EVO

About BANC Banc of California Inc.

Banc of California Inc is a financial holding company. It offers banking and financial services. Its services include banking services, lending services, and private banking services. Its deposit and banking product and service offerings include checking, savings, money market, certificates of deposit, and retirement accounts. Lending activities are focused on providing financing to California's diverse private businesses, entrepreneurs, and communities, and loans are often secured by California commercial and residential real estate. The company has one reportable segment named Commercial banking.

About EVO Evotec SE

Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.

Share on Social Networks: